Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML)

The presence of ‘measurable residual disease’ (MRD) is highly associated with relapse in patients achieving complete remission (CR) regardless of whether post-remission therapy includes allogeneic ...